【迈普医学：吉速亭外科适应证获批】据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。

金融界2025-01-10

据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2502888165?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-10 12:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2502888165","market":"hk","top_or_hot":-1,"title":"【迈普医学：吉速亭外科适应证获批】 据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。","media":"金融界","content":"<div>\n<p>据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/01/10124347328994.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【迈普医学：吉速亭外科适应证获批】 据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【迈普医学：吉速亭外科适应证获批】 据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-10 12:43 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/01/10124347328994.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/01/10124347328994.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"301033","symbol_name":"迈普医学","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/01/10124347328994.shtml","article_id":"2502888165","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2502888165","pubTimestamp":1736484196,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"301033":"迈普医学","BK0251":"专用设备"},"translate_title":"[Maipu Medicine: Jisuting's surgical indications were approved] According to Maipu Medicine, Jisuting's surgical indications for absorbable regenerative oxidized cellulose in ® were approved. In surgery, when ligation or other traditional hemostatic methods are inoperable or ineffective, this product is used as an auxiliary hemostatic product to control bleeding from capillaries, veins and arterioles.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"301033":1},"content_text":"据迈普医学消息，吉速亭®可吸收再生氧化纤维素外科适应证获批。在外科手术中，当结扎或其他传统的止血方法无法操作或无效时，该产品作为辅助止血产品用于控制毛细血管、静脉及小动脉的渗血。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2502888165","isCrawlerRequest":true}